DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 234 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $73,628 | -69.3% | 4,985 | -73.2% | 0.02% | -77.1% |
| Q2 2023 | $240,157 | +130.0% | 18,588 | +74.6% | 0.07% | +112.1% |
| Q1 2023 | $104,418 | -50.7% | 10,644 | -46.6% | 0.03% | -52.9% |
| Q4 2022 | $211,928 | +155.3% | 19,918 | +151.9% | 0.07% | +70.7% |
| Q3 2022 | $83,000 | -29.7% | 7,907 | -16.0% | 0.04% | -43.8% |
| Q2 2022 | $118,000 | +47.5% | 9,409 | +28.1% | 0.07% | +82.5% |
| Q1 2022 | $80,000 | +185.7% | 7,344 | +267.8% | 0.04% | +207.7% |
| Q4 2021 | $28,000 | +833.3% | 1,997 | +639.6% | 0.01% | +550.0% |
| Q2 2021 | $3,000 | +200.0% | 270 | +83.7% | 0.00% | 0.0% |
| Q1 2021 | $1,000 | – | 147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |